Emerging Infectious Diseases
A new report from the World Health Organization (WHO) shows that despite more countries recognizing and prioritizing the dangers of climate change and its potential impacts on health, they are not entirely acting to confront the situation.
Of 101 countries surveyed, half have developed a... Read More »
Faced with malaria parasites that are rapidly developing resistance to traditional front-line drugs, scientists from the Columbia University Vagelos College of Physicians and Surgeons have started to unravel the question of how with a new imaging study.
The focus of their photos was PfCRT, a... Read More »
The World Health Organization has reported 440,263 confirmed cases of measles as of Nov. 5., with most in Africa.
Specifically, in Africa, outbreaks are ongoing in Madagascar, Nigeria, and the Democratic Republic of the Congo. In the Congo, there are 250,270 suspected cases with 5,110... Read More »
Study leaders who put to the test four separate experimental therapies for use against Ebola virus disease (EVD) say that all have proven effective after halting a clinical trial of the treatments in August.
“Response teams have faced unprecedented challenges in ongoing efforts to save lives... Read More »
Artificial Intelligence could help medical experts detect tuberculosis (TB) in patients if Cleveland-based Diascopic LLC can successfully bring their diagnostic technology to market.
Aiding them in this endeavor is a federal business innovation grant -- the National Institute of Health Small... Read More »
The nation’s land grant universities play an important role in helping the federal government bolster agro-defense, according to scientists, policymakers, industry and academic leaders who participated in a recent Bipartisan Commission on Biodefense event held at Colorado State University... Read More »
Emergent BioSolutions announced the updated results of its Phase 2 clinical study evaluating the safety and immunogenicity of its chikungunya virus virus-like particle (CHIKV VLP) vaccine candidate across a series of dosing regimens.
The interim analysis showed that after the first dose, up to... Read More »
The Centers for Disease Control and Prevention (CDC) recently approved the reopening and partial operations of the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), the U.S. Department of Defense’s (DOD’s) lead laboratory for medical biological defense research.
This... Read More »
Cases of Rift Valley fever in Sudan have now reached 293 people, according to data gathered by the Program for Monitoring Emergency Diseases (ProMED) between Sept. 19, 2019, and Nov. 11, 2019.
The cases, which have led to 11 associated deaths, were reported in six states: the Red Sea, River... Read More »
The National Institute of Allergy and Infectious Diseases (NIAID) have begun to recognize eastern equine encephalitis (EEE) virus as an emergent threat, as an especially deadly year in the United States winds to a close.
As of Nov. 12, there were 36 confirmed cases of EEE across eight states,... Read More »
U.S. Reps. Anna Eshoo (D-CA) and Mario Diaz-Balart (R-FL) were honored by the Global Health Technologies Coalition (GHTC) for their leadership in supporting global health research and development (R&D).
The two were honored at GHTC’s 2019 Innovating for Impact Awards, which recognizes U.S.... Read More »
Researchers at Colorado State University were awarded a $1.2 million subcontract from the Infectious Disease Research Institute in Seattle for immunology research to accelerate progress in tuberculosis vaccine development.
The institute is part of the National Institutes of Health, which gave a... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) awarded a $6 million contract to Burlingame, Calif.-based Inflammatix Inc. to develop a new testing technology that reads gene expression patterns in the immune system.
The innovative technology, known as host-response testing,... Read More »
An online platform launched earlier this year crowdsources intelligence to predict the outcomes of disease outbreak.
The Johns Hopkins Center for Health Security implemented its publicly available disease prediction policy dashboard 10 months ago, and officials hope forecasting efforts might... Read More »
The U.S. Centers for Disease Prevention and Control (CDC) released the Antibiotic Resistance Threats Report this week, showcasing the effects recent federal investments have had in the fight against antibiotic resistance.
Since 2013, the annual number of antibiotic resistant infections in the... Read More »
The European Commission granted marketing authorization to Merck for a vaccine to immunize adults against Ebola Virus Disease (EVD) caused by the Zaire Ebola virus.
The vaccine, called ERVEBO, can be marketed in the 28 countries that are members of the European Union, as well as European... Read More »
Looking for ways to diagnose and treat infectious diseases in regions with limits health care and laboratories can yield some interesting results, but researchers from the University of Illinois at Urbana-Champaign are working on the development of a lab-on-a-smartphone to help expand the currently... Read More »
Techulon Inc. was awarded $785,000 to develop an antimicrobial that would kill drug-resistant bacteria by targeting specific genes critical to the bacteria’s survival.
The funding was from Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) – a global non-profit... Read More »
A study conducted by Stanford University under contract with the U.S. Food and Drug Administration (FDA) has been expanded to include new technologies capable of identifying viral reservoirs for both Ebola and Zika infections.
The study is part of a larger international effort to research how... Read More »
Researchers from Kansas State University say that a new risk assessment model for Ebola transmission accurately predicted the disease’s spread into the Republic of Uganda, opening the possibility of a better means of predicting disease spread.
"This is a very new type of model," Caterina... Read More »
Bat hunters in Nagaland, India, were found to have likely been exposed to filoviruses, according to a study from Duke-NUS Medical School researchers.
Filoviruses are part of a family that includes things like Ebola and Marburg viruses. This case continues to highlight the risks such viruses pose... Read More »
With the second-deadliest Ebola outbreak ever recorded still ongoing in the Democratic Republic of the Congo (DRC), the nation has opened itself to a second, large-scale vaccine trial backed by a global consortium.
The new vaccine candidate was created by Janssen Pharmaceutical Companies and... Read More »
Research efforts led by the Universities of Washington and Stanford have demonstrated that efficient tracking of widespread tropical disease spread could benefit from satellite images and drone photos.
"This is a game-changer for developing-country public health agencies because it will make it... Read More »
A new vaccine candidate -- MV-LASV -- for Lassa fever has started clinical trials, according to Themis Bioscience and the Coalition for Epidemic Preparedness Innovations (CEPI).
A Phase 1 trial is currently underway, with the vaccine administered to healthy volunteers. The vaccine used comes... Read More »
A set of three antibodies, recently identified by researchers sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), hold the promise of better treatments and vaccines for the flu.
In a paper published in Science last week, the researchers noted that the antibodies... Read More »
Scientists are rushing to find a vaccine for Lassa fever, and their efforts may have borne fruit in the form of a measles-platform based concoction that they now intend to put through human clinical trials by the end of the year.
Lassa, which infects up to 300,000 people per year and kills... Read More »
Researchers at the Los Alamos National Laboratory won the Centers for Disease Control and Prevention’s FluSight Challenge by providing the most accurate state, national, and regional flu forecasts in 2018.
The lab beat out 23 other teams with its probabilistic artificial intelligence computer... Read More »
Countries are not prepared for the possible international spread of new or emerging pathogens or for the deliberate or accidental release of dangerous agents, according to a new index that assesses the capabilities of 195 nations.
The Global Health Security Index is a joint project by the... Read More »
Under the terms of a seven-year contract with the National Institutes of Health (NIH), $60 million will be given to Dr. W. Henry Boom and a team of researchers from universities throughout the United States, in an effort to accelerate tuberculosis vaccine development.
The first year of the... Read More »
Antimicrobial resistant (AMR) microorganisms, also known as superbugs, increasingly threaten every person on Earth, according to the World Health Organization (WHO) and national experts.
“Antimicrobial resistance is one of the most urgent health risks of our time and threatens to undo a... Read More »
The U.S. Department of Defense (DoD) recently provided a three-year grant to Kansas State University (KSU) for the development of a tool used to assess infection risk and implementing prevention efforts.
Led by KSU professor Caterina Scoglio, PICTUREE: Predicting Insect Contact and Transmission... Read More »
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) gave the okay for a conditional marketing authorization for V920 Ebola Zaire vaccine developed by Merck.
If affirmed by the European Commission, the vaccine will be authorized under the brand name... Read More »
The ministries of health in Belize, Guatemala, and the Dominican Republic announced the development of a surveillance network to identify and track acute febrile illnesses (AFIs), now with the assistance of experts from the U.S. Centers for Disease Control and Prevention (CDC) and academic... Read More »
Tests conducted by National Institutes of Health scientists showed that a single dose of a highly diluted VSV-Ebola virus (EBOV) vaccine is fully protective against the disease in infected monkeys.
The dose is approximately one-millionth of what is in the vaccine being used to help control the... Read More »
New cases in the ongoing Democratic Republic of the Congo (DRC) Ebola outbreak slowed in the 21 days from Sept. 23 to Oct. 13, 2019, a World Health Organization (WHO) Emergency Committee heard this week.
While the epidemic is primarily concentrated on the Mandima health zone in the DRC, new... Read More »
